Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 5—May 2017

Increased Neurotropic Threat from Burkholderia pseudomallei Strains with a B. mallei–like Variation in the bimA Motility Gene, Australia

Jodie L. MorrisComments to Author , Anne Fane, Derek Sarovich, Erin P. Price, Catherine M. Rush, Brenda L. Govan, Elizabeth Parker, Mark Mayo, Bart J. Currie, and Natkunam Ketheesan
Author affiliations: James Cook University, Townsville, Queensland, Australia (J.L. Morris, A. Fane, C.M. Rush, B.L. Govan, E. Parker, N. Ketheesan); Menzies School of Health Research, Darwin, Northern Territory, Australia (D.S. Sarovich, E.P. Price, M. Mayo, B.J. Currie); Royal Darwin Hospital, Darwin (B.J. Currie)

Main Article


Clinical and patient characteristics and sequence type diversity of bimBm and bimBp Burkholderia pseudomallei isolates, Australia

Isolate no. Age, y/sex Risk factors Clinical presentation Outcome MLST genotype
MSHR62 23/M None Brainstem encephalitis Survived 148
MSHR435 37/M None Brainstem encephalitis Survived 126
MSHR543 22/F None Skin ulcer Survived 294
MSHR668 53/M None Diffuse encephalitis Survived 129
MSHR1153 59/M DBT Brainstem encephalitis Died 117
MSHR2138 49/F DBT Bacteremia Survived 456
Brainstem encephalitis
MSHR305 64/M ALC Encephalitis, myelitis Died 36
MSHR346 49/M ALC, COPD Pneumonia Survived 243
MSHR465 67/M DBT, COPD Pneumonia, septic shock Died 132
MSHR1655 61/F COPD Pneumonia Survived 131
MSHR3709 14/M None Brainstem encephalitis Survived 132
MSHR974* 16/F None Skin ulcer Survived 554
MSHR4237* 45/F None Pneumonia Survived 868
NCTC13179 54/M DBT Skin ulcer Survived 613

*Additional isolates included for internalization and persistence assays. ALC, hazardous alcohol use; COPD, chronic obstructive pulmonary disease; DBT, diabetes; MLST, multilocus sequence typing.

Main Article

Page created: April 14, 2017
Page updated: April 14, 2017
Page reviewed: April 14, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.